期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
The Physiopathological Crossroads of Aging
1
作者 J.Lasierra-Cirujeda P.Coronel +4 位作者 M.J.aza pascual-salcedo M.Gimeno M.M.Aza Pascual Salcedo A.Lasierra-Ibanez C.Lasala-Aza 《Journal of Biosciences and Medicines》 2019年第6期102-128,共27页
Stress, inflammation and Plasminogen activator inhibitor 1 (PAI-1) are key mechanisms throughout the development of aging, constituting a crossroad in the most frequent pathologies that accompany it. Among metabolic p... Stress, inflammation and Plasminogen activator inhibitor 1 (PAI-1) are key mechanisms throughout the development of aging, constituting a crossroad in the most frequent pathologies that accompany it. Among metabolic processes, obesity, metabolic syndrome and type 2 diabetes mellitus are included and Alzheimer’s disease among the neurodegenerative processes. Stress is a mechanism of defense of the organism against exogenous and endogenous actions called stressors. In the case of low intensity stimuli, the organism responds with actions aimed at a physiological adaptation (Homeostasis). On the other hand, when a high intensity (experimental level) or chronic stimulus (oxidative stress) is repeated, structural and functional changes are observed in different organs with activation of the hypothalamus-pituitary-adrenal axis, the renin angiotensin system and the sympathetic nervous system, stimulating the production of hormones that release cytokines with proin-flammatory/antiinflammatory properties that play an important role in the previously mentioned pathologies, as well as a marked increase in PAI-1, a gene regulated by stress and by cytokines, with manifest action at the origin of thromboembolic disease, so frequent in aging. The objective of this review is to highlight the importance of the binomial stress and PAI-1 in aging and in the pathologies that accompany it. Because PAI-1 is part of the pathology and complications in aging, some authors suggest the study of PAI-1 inhibitors to achieve its physiological levels, as part of the treatment of these diseases. 展开更多
关键词 Aging. Oxidative stress Plasminogen Activator Inhibitor 1 transforming growth factor Beta 1 GLUTATHIONE alzheimer’s disease
下载PDF
阿尔茨海默病患者血清TGF-β_1含量观察与分析 被引量:4
2
作者 吴学玲 王先酉 +1 位作者 周志明 李喜兵 《实用心脑肺血管病杂志》 2003年第3期139-140,共2页
目的 探讨转化生长因子 β1 在阿尔茨海默病发生中的作用。 方法 用双抗体夹心ELISA法检测32例阿尔茨海默病患者和 2 0例正常人血清TGF β1 含量 ,两者加以比较。 结果 阿尔茨海默病组TGF β1 含量明显低于正常组 ,两组间存在显著... 目的 探讨转化生长因子 β1 在阿尔茨海默病发生中的作用。 方法 用双抗体夹心ELISA法检测32例阿尔茨海默病患者和 2 0例正常人血清TGF β1 含量 ,两者加以比较。 结果 阿尔茨海默病组TGF β1 含量明显低于正常组 ,两组间存在显著性差异 (t =2 87,0 0 0 5 <P <0 0 1) (双侧 )。 结论 TGF β1 可能通过影响细胞的增殖分化、神经元转移及轴突形成、抗原表达及细胞毒等作用 。 展开更多
关键词 阿尔茨海默病 血清 TGF-Β1 含量 临床观察 转化生长因子
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部